Chenguang Biotech Overview
- Year Founded
-
1998
- Status
-
Public
- Employees
-
2,009
- Stock Symbol
-
300138
- Share Price
-
$1.26
- (As of Tuesday Closing)
Chenguang Biotech General Information
Description
Chenguang Biotech Group Co Ltd is engaged in the processing of agricultural products and herb extracts in China. Its products include natural colors, including paprika oleoresin, marigold oleoresin, curcumin, red rice red, red cabbage, and red beet; and natural spice extracts and essential oils, such as capsicum oleoresin, zanthoxylum oil and oleoresin, black pepper oil and oleoresin, ginger oil and oleoresin, turmeric oil, star anise oil and oleoresin, cumin oil and oleoresin, garlic oil and oleoresin, and common fennel oil and oleoresin.
Contact Information
Website
www.cn-cg.comCorporate Office
- No.1 Chenguang Road
- Quzhou, Hebei 057250
- China
Corporate Office
- No.1 Chenguang Road
- Quzhou, Hebei 057250
- China
Chenguang Biotech Stock Performance
As of 03-Dec-2024, Chenguang Biotech’s stock price is $1.26. Its current market cap is $608M with 483M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.26 | $1.26 | $0.97 - $1.97 | $608M | 483M | 11.4M | $0.04 |
Chenguang Biotech Financials Summary
As of 30-Sep-2024, Chenguang Biotech has a trailing 12-month revenue of $965M.
|
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 989,319 | 1,142,770 | 1,438,805 | 1,479,630 |
| Revenue | 965,090 | 971,255 | 934,863 | 754,770 |
| EBITDA | 31,269 | 106,930 | 102,381 | 88,700 |
| Net Income | 20,057 | 67,806 | 64,449 | 54,439 |
| Total Assets | 1,105,164 | 1,204,692 | 1,003,542 | 934,275 |
| Total Debt | 576,057 | 597,527 | 411,674 | 383,599 |
Chenguang Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Chenguang Biotech Patents
Chenguang Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230219872-A1 | Industrial extraction method of cannabidiol | Pending | 16-Jun-2020 | ||
| EP-4148111-A1 | Grease composition having good stability | Pending | 06-May-2020 | ||
| US-20230348814-A1 | Oil composition having good stability | Pending | 06-May-2020 | ||
| EP-4148111-A4 | Grease composition having good stability | Pending | 06-May-2020 | ||
| US-20230122252-A1 | Composition containing quercetagetin | Pending | 10-Mar-2020 | A23L33/105 |
Chenguang Biotech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Chenguang Biotech FAQs
-
When was Chenguang Biotech founded?
Chenguang Biotech was founded in 1998.
-
Where is Chenguang Biotech headquartered?
Chenguang Biotech is headquartered in Quzhou, China.
-
What is the size of Chenguang Biotech?
Chenguang Biotech has 2,009 total employees.
-
What industry is Chenguang Biotech in?
Chenguang Biotech’s primary industry is Food Products.
-
Is Chenguang Biotech a private or public company?
Chenguang Biotech is a Public company.
-
What is Chenguang Biotech’s stock symbol?
The ticker symbol for Chenguang Biotech is 300138.
-
What is the current stock price of Chenguang Biotech?
As of 03-Dec-2024 the stock price of Chenguang Biotech is $1.26.
-
What is the current market cap of Chenguang Biotech?
The current market capitalization of Chenguang Biotech is $608M.
-
What is Chenguang Biotech’s current revenue?
The trailing twelve month revenue for Chenguang Biotech is $965M.
-
What is Chenguang Biotech’s annual earnings per share (EPS)?
Chenguang Biotech’s EPS for 12 months was $0.04.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
